Photosensitizers
(PSs) have greatly flourished as a promising tool
for photodynamic therapy owing to their integration of both in situ
diagnosis and treatment in a single nanoplatform. However, there is
still a need to explore synthesis pathways that can result in high-performance
PSs with good reproducibility, high yield, less dark toxicity, and
an attractive therapeutic index. Therefore, by exploiting the precise
molecular engineering guideline, this work unveils a straightforward
protocol to fabricate three homologous PSs (TPA-T-RS, TPA-Ts-RS, and
TPA-Ts-RCN) with aggregation-induced emission (AIE) characteristics.
Through slight structural tuning, the PSs are capable of anchoring
to the cell membrane, mitochondria, and lysosome, and effectively
generating reactive oxygen species (ROS). More importantly, TPA-Ts-RCN
proved an intuitively appealing imaging-guided photodynamic therapy
(PDT) effect. This work is expected to add a promising dimension to
the field of architecting AIE PSs for image-guided photodynamic therapy.